| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |